(11/6/25) The Guardian Weight loss drugs linked to higher risk of eye damage in diabetic patients Study finds medicines such as Ozempic are associated with a greater risk of developing age-related macular degeneration (5/6/25) Whats the risk
For pure results, tirzepatide often delivers greater average weight loss and stronger blood sugar improvement compared with semaglutide in head to head studies, yet some people respond incredibly well to semaglutide, so the choice usually comes down to how much weight needs to be lost, how aggressive the treatment should be, the impact on A1C, and how the body tolerates dose increases, and ongoing follow ups with a clinician help fine tune which drug and dose give the best outcome
Maybe hold off on that second helping of pasta? Semaglutide mimics a natural hormone called GLP-1, which plays a key role in appetite control and blood sugar regulation
Lupus, Sjgrens, and Ankylosing Spondylitis and More GLP-1s may calm immune responses, offset steroid-induced weight gain, protect the kidneys, and lower heart disease risk